From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson's disease. Scientific commentary on: "Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease".
Saved in:
| Title: | From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson's disease. Scientific commentary on: "Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease". |
|---|---|
| Authors: | Shebl N; Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt., Salama M; Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt. Mohamed-Salama@aucegypt.edu.; Global Brain Health Institute (GBHI), Trinity College Dublin, Dublin 2, Ireland. Mohamed-Salama@aucegypt.edu.; Faculty of Medicine, Mansoura University, El Mansûra, Egypt. Mohamed-Salama@aucegypt.edu. |
| Source: | Acta neuropathologica [Acta Neuropathol] 2024 May 18; Vol. 147 (1), pp. 88. Date of Electronic Publication: 2024 May 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
